Showing results (1-10 of 432) with videos related to
Sort By:
Pageof 44
Mutation Research|November 1, 1988
Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificityB René, C Auclair, R P Fuchs, et al.Biochemical and Biophysical Research Communications|July 31, 1986
Frameshift mutagenesis in Salmonella typhimurium by reversible DNA intercalators: effect of a UVR B mutationB René, C Auclair, C PaolettiMutation Research|May 1, 1988
Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coliB René, C Auclair, C PaolettiBiochimie|March 1, 1985
Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimuriumB René, H Banoun, C Auclair, et al.Biochemistry|November 4, 1986
Relationship between cytostatic activity of oxazolopyridocarbazoles and accessibility of DNA intercalation sites in living bacteriaH Banoun, B René, C Auclair, et al.Journal of Medicinal Chemistry|March 1, 1981
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide systemC Auclair, C PaolettiJournal of Medicinal Chemistry|October 1, 1983
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivativesC Auclair, K Hyland, C PaolettiBiochemical and Biophysical Research Communications|September 16, 1985
A revised structure of the antitumor drug elliptinium--amino(acid) adductsA Gouyette, C Auclair, C PaolettiBiochemistry|March 25, 1986
Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitroC Auclair, B Dugué, B Meunier, et al.Anticancer Research|July 1, 1987
Isolation and characterization of the glutathione-elliptinium conjugate in human urineA Gouyette, E Voisin, C Auclair, et al.Pageof 44